Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
02/2002
02/12/2002US6346656 Increasing resistance of plants or algal cells by genetically engineering a unicellular green alga resistant to porphyrin herbicides
02/12/2002US6346608 MecB
02/12/2002US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus
02/12/2002US6346606 A protein; diagnosis and therapy for tumor diseases, central nervous system diseases, glioblastomas, and breast cancer
02/12/2002US6346510 Antiproliferative, anticarcinogenic and antitumor agents
02/12/2002US6346410 Motor proteins and methods for their use
02/12/2002US6346409 Tryptophenyl tRNA synthetase from Streptococcus pneumoniae
02/12/2002US6346407 Xylanase, microorganisms producing it, DNA molecules, methods for preparing this xylanase and uses of the latter
02/12/2002US6346406 Elongation factor-2 kinase (EF-2 kinase), and methods of use therefor
02/12/2002US6346405 Amino acid sequence of enzyme involved in aromatic amino acid biosynthesis; fungicides
02/12/2002US6346404 Genes for the biosynthesis of epothilones
02/12/2002US6346394 Dna having specific nucleotide sequence; for recombinant production of enzyme and high yield, industrial scale production of trehalose
02/12/2002US6346393 Polynucleotides encoding a ribonuclease s
02/12/2002US6346392 Amino acid sequence from streptococcus; drug screening of bactericides and bacteriostats
02/12/2002US6346381 Determination whether nucleotides from individual have one or more pg1-related biallelic markers or mutants; medical diagnosis
02/12/2002US6346379 Thermostable DNA polymerases incorporating nucleoside triphosphates labeled with fluorescein family dyes
02/12/2002US6346246 Antibodies that bind human haemopoietic maturation factor
02/12/2002US6346244 Fungal protein disulfide isomerase
02/12/2002CA2215187C Addition of lactose or other sugars in correcting false susceptibility results for resistant microorganisms in antimicrobial susceptibility tests
02/12/2002CA2214871C Process for preparing spirolaxine and spirolaxine methyl ether
02/12/2002CA2068204C Latency associated peptides and uses therefor
02/12/2002CA1341339C Arg-serpin human plasminogen activator inhibitor designated pai-2
02/09/2002CA2354726A1 Sodium ion-driven chloride/bi-carbonate exchanger
02/08/2002CA2353772A1 Process for producing a target fermentation product
02/07/2002WO2002010766A2 Assay method, peptides and reagent kits for testing mrp-specific inhibitors
02/07/2002WO2002010435A1 Methods of screening novel agents for use in cancer therapy and prevention
02/07/2002WO2002010426A1 Koji molds and use thereof for preparing cholesterol-lowering products
02/07/2002WO2002010425A2 Ascorbic acid production from yeasts
02/07/2002WO2002010420A2 Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof
02/07/2002WO2002010416A1 IMPROVED VIRUS LIKE PARTICLES BASED ON SMALL ENVELOPE PROTEIN FROM HEPATITIS B (HBsAg-S)
02/07/2002WO2002010411A2 Preparation of a recombinant protein in a prokaryotic host cell by improved codon use
02/07/2002WO2002010406A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof
02/07/2002WO2002010405A2 A human disintegrin protein
02/07/2002WO2002010403A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
02/07/2002WO2002010402A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides
02/07/2002WO2002010399A1 Novel carbonyl reductase, gene thereof and method of using the same
02/07/2002WO2002010394A2 Nucleic acids, by means of which plants with altered metabolite content can be produced
02/07/2002WO2002010388A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
02/07/2002WO2002010387A2 G-protein coupled receptors
02/07/2002WO2002010384A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin
02/07/2002WO2002010383A1 Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin
02/07/2002WO2002010382A2 Trp8, trp9 and trp10, markers for cancer
02/07/2002WO2002010381A1 Novel protein inhibitor of apoptosis proteins
02/07/2002WO2002010376A1 HUMAN II TYPE 5α-REDUCTASE PROMOTER GENE AND USE THEREOF
02/07/2002WO2002010369A1 Tumor antigen
02/07/2002WO2002010363A2 Protein phosphatases
02/07/2002WO2002010360A1 Novel dna synthase
02/07/2002WO2002010355A2 Alpha-amylase mutants with altered stability
02/07/2002WO2002010343A2 Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
02/07/2002WO2002010342A2 Yeast strains
02/07/2002WO2002010341A1 Microsporidia isolate
02/07/2002WO2002010340A1 $i(neospora caninum) isolate
02/07/2002WO2002010333A1 Method for cellular lysis of prokaryotes and eukaryotes or simultaneous cellular lysis or prokaryotes and eukaryotes
02/07/2002WO2002010217A2 Endothelial cell expression patterns
02/07/2002WO2002010216A2 Proteins and nucleic acids encoding same
02/07/2002WO2002010214A2 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
02/07/2002WO2002010209A1 Nucleotide sequences which code for the meth gene
02/07/2002WO2002010208A1 Nucleotide sequences which code for the mete gene
02/07/2002WO2002010206A2 Nucleotide sequences which code for the metf gene
02/07/2002WO2002010204A2 G protein-coupled receptors
02/07/2002WO2002010199A2 C3b/c4b complement receptor-like molecules and uses thereof
02/07/2002WO2002010196A2 Identification of a novel glutamine transporter
02/07/2002WO2002009872A2 Biodehalogenating cultures and production thereof
02/07/2002WO2002009647A2 Biological component comprising artificial membrane
02/07/2002WO2002002778A8 Nucleotide sequences which code for the mdha gene from corynebacterium glutamicum
02/07/2002WO2001079507A3 EXPRESSION-REGULATING SEQUENCES AND EXPRESSION PRODUCTS IN THE FIELD OF FILAMENTOUS FUNGI $i(CHRYSOSPORIUM)
02/07/2002WO2001075066A3 Dna molecules and polypeptides of pseudomonas syringae hrp pathogenicity island and their uses
02/07/2002WO2001064878A3 Human transporter proteins and polynucleotides encoding the same
02/07/2002WO2001059127A3 Drug metabolizing enzymes
02/07/2002WO2001057193A3 Protein c derivatives
02/07/2002WO2001055329A3 Nucleic acids, proteins, and antibodies
02/07/2002WO2001055315A3 Nucleic acids, proteins, and antibodies
02/07/2002WO2001055297A3 Three-dimensional matrix body, and device and method for measuring contractions of a cell tissue
02/07/2002WO2001055211A3 Fil-1 theta dnas and polypeptides
02/07/2002WO2001053469A3 Phosphatases
02/07/2002WO2001053347A3 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
02/07/2002WO2001032831A3 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins
02/07/2002WO2001031047A3 Microbiological methods for the producing of aromatic aldehydes and/or carboxylic acids
02/07/2002WO2001029233A3 Chimeric immunogenic compositions and nucleic acids encoding them
02/07/2002WO2001029224A3 Granulocyte peptide homolog zgpa1
02/07/2002WO2001018216A3 26176, a novel calpain protease and uses thereof
02/07/2002WO2001018050A9 T2r taste receptor family
02/07/2002WO2001002587A3 Novel antifungal agents and fungicides, method for the production thereof and their use
02/07/2002WO2000068376A8 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
02/07/2002US20020016450 Pressure-enhanced extraction and purification
02/07/2002US20020016446 Recombinant vector and use thereof for exocellular preparation of single molecula antibodies from bacillus subtilis
02/07/2002US20020016445 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen
02/07/2002US20020016305 Yeast genes that affect viral replication
02/07/2002US20020016303 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease.
02/07/2002US20020015990 Nutrient broth for use in the propagation of preferential microorgansim and generation of foods
02/07/2002US20020015988 Granular formulation containing microorganisms, a process for the preparation and the use thereof
02/07/2002US20020015987 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects
02/07/2002US20020015983 Escherichia coli csrB gene, RNA encoded thereby, and methods of use thereof
02/07/2002US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer
02/07/2002US20020015950 Atherosclerosis-associated genes
02/07/2002US20020015757 Xanthan gum broth
02/07/2002US20020015038 System and method for evaluating pockets in protein
02/07/2002DE10048383A1 Protonen-translozierendes Retinalprotein Proton-translocating retinal protein
02/07/2002DE10037111A1 Herstellung eines rekombinanten Proteins in einer prokaryontischen Wirtszelle Producing a recombinant protein in a prokaryotic host cell
02/07/2002DE10037101A1 Rekombinant hergestellte Enzyme mit verbesserter NAD(H)-Akzeptanz Recombinantly produced enzymes with improved NAD (H) -Akzeptanz